AzTrials
AzTrials

SmokingEarly Phase 1NCT00981396

The Effect of Emotional Freedom Techniques (EFT) in Smokers Failing a Smoking Cessation Program

A Early Phase 1 study testing EFT (Emotional Freedom Techniques) and CBT (Cognitive Behavioral Therapy) in people with Smoking, run by Soul Medicine Institute at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The National Health Service (NHS) stop smoking service at the Central Lancashire NHS Trust serves a diverse population of smokers, with a very good quit rate and high standards. However, clinical experience predicts that some clients are unlikely to succeed through the NHS smoking cessation program. Read more about this study

Who is it for?
Ages 12 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Smoking
What is being tested?
EFT (Emotional Freedom Techniques) and CBT (Cognitive Behavioral Therapy)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited Kingdom
Study dates
20 Sep 2009to 31 Dec 2027
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • High anxiety related to the quit attempt
  • Cravings which sabotage the quit attempt
  • Low confidence at their ability to quit and remain quit

Who cannot join

  • None, all NHS clients are eligible

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site, 1 recruiting
  • NHS Central Lancashire Primary Care Trust

    Ormskirk, Lancashire, L39 2JW

    Dawson Church, 707 237 6951, dawsonchurch@gmail.com

    Joan Draper, LPC

    Recruiting

Other trials in United Kingdom

About this study

Official title: The Effect of EFT (Emotional Freedom Techniques) in Smokers Failing a Smoking Cessation Program

The National Health Service (NHS) stop smoking service at the Central Lancashire NHS Trust serves a diverse population of smokers, with a very good quit rate and high standards. However, clinical experience predicts that some clients are unlikely to succeed through the NHS smoking cessation program. This special population has difficulty quitting for a variety of reasons. Some relapse over the course of the following two years and return repeatedly to the service. Others, for instance those with health problems, may be highly motivated to quit, but unable to resist their cravings. The purpose of this study is to determine if EFT makes a difference in quit rates with the most challenging population of clients.

Conditions
Smoking
Being tested
EFT (Emotional Freedom Techniques), CBT (Cognitive Behavioral Therapy)
Keywords
smoking, EFT (Emotional Freedom Techniques), CBT (cognitive behavior therapy), cravings, trauma
Medical subject headings
Smoking, Color Vision Defects, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EFT (Emotional Freedom Techniques)Behavioural

    EFT is a brief but efficacious stress-reduction intervention. It combines exposure, cognitive structuring, and somatic stimulation.

  • CBT (Cognitive Behavioral Therapy)Behavioural

    CBT is a behavioral intervention that seeks to challenge and change negative client cognitions about events and life circumstances.

Study groups in NCT00981396
Study groupRoleWhat they receive
CBTActive comparatorCognitive Behavioral Therapy
Receives: Behavioral: CBT (Cognitive Behavioral Therapy)
EFTExperimentalEmotional Freedom Techniques, a novel but efficacious stress-reduction technique
Receives: Behavioral: EFT (Emotional Freedom Techniques)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quit rate

    Measured: treatment period

Secondary outcomes (1)
  1. Psychological symptoms and physiological symptoms

    Symptoms and smoking 3, 6 and 12 months post-intervention

    Measured: Three, 6, and 12 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2009 (estimated)
  2. Study start20 Sep 2009
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00981396
Sponsor's protocol ID
SMI-SMO-92509
Status last verified
Apr 2026
First submitted
19 Sep 2009
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing EFT (Emotional Freedom Techniques) and CBT (Cognitive Behavioral Therapy) in people with Smoking, run by Soul Medicine Institute at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joan Draper, LPC (01695 588000, joan.draper@btinternet.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quit rate (time frame: treatment period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in